NCT03429075View on ClinicalTrials.gov

Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

January 7, 2019

Primary Completion Date

April 17, 2020

Study Completion Date

October 17, 2020

Conditions
Depressive Disorder, Major
Interventions
DRUG

Psilocybin + Placebo

Multiple dosing days psilocybin vs 6 weeks of daily placebo

DRUG

Psilocybin + Escitalopram

Multiple dosing days psilocybin vs 6 weeks of daily escitalopram

Trial Locations (1)

W12 0NN

Imperial College Hammersmith campus, London

All Listed Sponsors
collaborator

Alexander Mosely Charitable Trust

OTHER

lead

Imperial College London

OTHER

NCT03429075 - Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms | Biotech Hunter | Biotech Hunter